Groups recommend HER2 testing to all women with invasive breast cancer

10/7/2013 | HealthDay News

The American Society of Clinical Oncology and the College of American Pathologists released guidelines urging all women with invasive breast cancer to be screened for the human epidermal growth factor receptor 2 gene and protein. Women with HER2-positive cancer should get HER2-targeted therapies, and those treatments should be not used for HER2-negative cancers, according to the guidelines published in the Journal of Clinical Oncology and the Archives of Pathology & Laboratory Medicine.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL